Fig. 6: Adjuvant chemotherapy benefits based on DMFS according to pN stage and RS.
From: Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer
a–c K–M DMFS curves are shown for patients according to their use of adjuvant chemotherapy. In addition, patients with a high RS (left) were stratified according to pN0 (n = 141, upper), pN1 (n = 85, middle), and pN2 (n = 53, bottom). Patients with a low RS (right) were also stratified according to pN0 (n = 218, upper), pN1 (n = 89, middle), and pN2 (n = 43, bottom). p values were calculated using two-sided log-rank test. RS radiomic signature; HR hazard ratio; DMFS distant metastasis-free survival; LARC locally advanced rectal cancer. Source data are provided as a Source Data file.
